Medicine | Oncology
CNS Tumors
Diffuse astrocytic and oligodendroglial tumors

Oligodendroglioma


ONLINEARCHIVES.ORG > Disciplines > Medicine > Oncology > CNS Tumors > Diffuse astrocytic and oligodendroglial tumors > Oligodendroglioma



CONTENTS



CASE REPORTS
CLASSIFICATION
DIAGNOSIS
EPIDEMIOLOGY, RISK FACTORS
ETIOLOGY, PATHOGENESIS, PATHOLOGY
FOLLOW-UP, QUALITY OF LIFE
INTEGRATIVE MEDICINE
OVERALL MANAGEMENT
PROGNOSIS
TREATMENT



Case reports




MULTICENTRIC



Vats A, Amit A, Doshi P.
Multicentric high grade oligodendroglioma: a rare entity.
Br J Neurosurg. 2017 Oct 27:1-3. doi: 10.1080/02688697.2017.1396582. [Epub ahead of print]
Source | Abstract | Full text | Similar articles



SARCOMA-LIKE TUMOR



Shoji T, Saito R, Kanamori M, Sonoda Y, Watanabe M, Tominaga T.
Sarcoma-like tumor originating from oligodendroglioma.
Brain Tumor Pathol. 2016 Jun 22. [Epub ahead of print]
Source | Abstract | Full text | Similar articles



Prognosis





Achey RL, Khanna V, Ostrom QT, Kruchko C, Barnholtz-Sloan JS.
Incidence and survival trends in oligodendrogliomas and anaplastic oligodendrogliomas in the United States from 2000 to 2013: a CBTRUS Report.
J Neurooncol. 2017 Apr 10. doi: 10.1007/s11060-017-2414-z. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Goel NJ, Abdullah KG, Lang SS.
Outcomes and Prognostic Factors in Pediatric Oligodendroglioma: A Population-Based Study.
Pediatr Neurosurg. 2017 Nov 2. doi: 10.1159/000481458. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Zetterling M, Berhane L, Alafuzoff I, Jakola AS, Smits A.
Prognostic markers for survival in patients with oligodendroglial tumors; a single-institution review of 214 cases.
PLoS One. 2017 Nov 29;12(11):e0188419. doi: 10.1371/journal.pone.0188419. eCollection 2017.
Source | Abstract | Full text | Similar articles



Treatment




CHEMOTHERAPY


.

Iwadate Y, Matsutani T, Hara A, Hirono S, Ikegami S, Kobayashi M, Ito D, Kawauchi D, Horiguchi K, Tamiya A, Higuchi Y.
Eighty percent survival rate at 15 years for 1p/19q co-deleted oligodendroglioma treated with upfront chemotherapy irrespective of tumor grade.
J Neurooncol. 2019 Jan;141(1):205-211. doi: 10.1007/s11060-018-03027-5. Epub 2018 Dec 18.
Source | Full text | Similar articles



SURGERY



Alattar AA, Brandel MG, Hirshman BR, Dong X, Carroll KT, Ali MA, Carter BS, Chen CC.
Oligodendroglioma resection: a Surveillance, Epidemiology, and End Results (SEER) analysis.
J Neurosurg. 2017 May 12:1-8. doi: 10.3171/2016.11.JNS161974. [Epub ahead of print]
Source | Abstract | Full text | Similar articles



°